David Ricks

• 1/18/2025

  Eli Lilly’s Revenue Outlook Slumps Amidst Fierce Competition

• 1/16/2025

  Eli Lilly’s Q4 Revenue Guidance Falls Short, Shares Tumble 6%

• 11/1/2024

  Eli Lilly’s Q3 Earnings Disappoint: Sales of Blockbuster Drugs Fall Short